Home > Compound List > Product Information
Cabazitaxel_Molecular_structure_CAS_183133-96-2)
Click picture or here to close

Cabazitaxel

Catalog No. C046500 Name Toronto Research Chemicals
CAS Number 183133-96-2 Website http://www.trc-canada.com
M. F. C45H57NO14 Telephone +1 (416) 665-9696
M. W. 835.93238 Fax +1 (416) 665-4439
Purity Email info@trc-canada.com
Storage -20°C Freezer Chembase ID: 163519

SYNONYMS

IUPAC name
(1S,2S,3R,4S,7R,9R,10S,12S,15S)-4-(acetyloxy)-15-{[(2R,3S)-3-{[(tert-butoxy)carbonyl]amino}-2-hydroxy-3-phenylpropanoyl]oxy}-1-hydroxy-9,12-dimethoxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-2-yl benzoate
IUPAC Traditional name
(1S,2S,3R,4S,7R,9R,10S,12S,15S)-4-(acetyloxy)-15-{[(2R,3S)-3-[(tert-butoxycarbonyl)amino]-2-hydroxy-3-phenylpropanoyl]oxy}-1-hydroxy-9,12-dimethoxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-2-yl benzoate
Synonyms
β-[[(1,1-Dimethylethoxy)carbonyl]amino]-α-hydroxybenzenepropanoic Acid [2aR-[2aα,4β,4aβ,6β,9α(αR*,βS*),11α,12α,12aα,12bα]]-12b-(Acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-11-hydroxy-4,6-dimethoxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl Ester
TXD 258
XRP 6258
(αR,βS)-β-[[(1,1-Dimethylethoxy)carbonyl]amino]-α-hydroxybenzenepropanoic Acid (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-12b-(Acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-11-hydroxy-4,6-dimethoxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl Ester

DATABASE IDS

CAS Number 183133-96-2

PROPERTIES

MSDS Link Download
Storage Condition -20°C Freezer
Certificate of Analysis Download
Apperance White Solid
Melting Point 181-183°C
Solubility DMSO
Solubility Methanol

DETAILS

Description (English)
A novel semi-synthetic taxane with antitumor activity used for the treatment of castration-resistant prostate cancer. A microtubule inhibitor.

REFERENCES

  • Agarwal, N. et al.: Fut. Oncol., 7, 15 (2011)
  • Mita, A. et al.: Clin. Cancer Res., 15, 723 (2011)
  • Figg, W.D. et al.: Cancer Biol. Ther., 10, 1233 (2011)